Transmission electron micrograph of part of the norovirus pathogen
BSIP SA/Alamy
global international trial Development of an mRNA vaccine against norovirus is underway, with the aim of reducing the health burden caused by the notorious “winter vomiting” disease. The trial has been complicated by the emergence of a new strain of norovirus that is causing a surge in cases in parts of the world, including the UK.
“Unfortunately, one of the most prevalent strains is not in that jab,” said Patrick Moore from the UK National Institute for Health and Care Excellence, who is leading the UK arm of the trial. “The high case is probably…
Source: www.newscientist.com
